Laura Valiente González1, Ricardo de Miguel Ibáñez2, Francisco Escribano Sotos3. 1. Department of Gastroenterology, Virgen de La Luz Hospital, Cuenca, Spain. lvalienteg@sescam.jccm.es. 2. Department of General and Digestive Surgery, Virgen de La Luz Hospital, Cuenca, Spain. 3. Faculty of Economics and Business Administration, University of Castilla-La Mancha, Albacete, Spain.
Abstract
BACKGROUND: Colorectal cancer is the most commonly diagnosed cancer type and the second cause of cancer death in Spain. The primary risk factor for colorectal cancer is age, with 90% of all diagnosed patients aged over 50 years. Prognosis mainly depends on tumour stage. AIM: Conduct a colorectal cancer prevalence and survival study in Cuenca (Spain) since there are almost no studies based on small populations. This is the first study about survival in screening of colorectal cancer carried out in hospitals in Castilla-La Mancha. METHODS: Retrospective descriptive cohort study was performed to include patients with colorectal cancer diagnosed by colonoscopy between May 2015 and April 2016, and who were followed up for 48 months. The study considered sociodemographic and clinical data of the patients. Survival curves were estimated using the Kaplan-Meier method. The proportional hazard rate associated with age, gender, stage, and presence of metastasis was calculated using the Cox regression method. RESULTS: Fifty-seven patients were included in the study. The mean follow-up was 45.5 months. Ten patients died during the study; in seven cases, the cause was colorectal cancer. The percentage of patients alive at a 48-month follow-up was 82.4%. CONCLUSION: Colon cancer is a high-prevalence pathology, with adenocarcinoma being the most common histology. The results seem to indicate that it affects men more frequently, mortality rises with tumour stage at diagnosis and declines with use of chemotherapy. We present a study that could justify large-scale epidemiological studies for the regional surveillance and evolution of colorectal cancer in Spain.
BACKGROUND: Colorectal cancer is the most commonly diagnosed cancer type and the second cause of cancer death in Spain. The primary risk factor for colorectal cancer is age, with 90% of all diagnosed patients aged over 50 years. Prognosis mainly depends on tumour stage. AIM: Conduct a colorectal cancer prevalence and survival study in Cuenca (Spain) since there are almost no studies based on small populations. This is the first study about survival in screening of colorectal cancer carried out in hospitals in Castilla-La Mancha. METHODS: Retrospective descriptive cohort study was performed to include patients with colorectal cancer diagnosed by colonoscopy between May 2015 and April 2016, and who were followed up for 48 months. The study considered sociodemographic and clinical data of the patients. Survival curves were estimated using the Kaplan-Meier method. The proportional hazard rate associated with age, gender, stage, and presence of metastasis was calculated using the Cox regression method. RESULTS: Fifty-seven patients were included in the study. The mean follow-up was 45.5 months. Ten patients died during the study; in seven cases, the cause was colorectal cancer. The percentage of patients alive at a 48-month follow-up was 82.4%. CONCLUSION: Colon cancer is a high-prevalence pathology, with adenocarcinoma being the most common histology. The results seem to indicate that it affects men more frequently, mortality rises with tumour stage at diagnosis and declines with use of chemotherapy. We present a study that could justify large-scale epidemiological studies for the regional surveillance and evolution of colorectal cancer in Spain.
Authors: Petur Snaebjornsson; Larus Jonasson; Elinborg J Olafsdottir; Nicole C T van Grieken; Pall H Moller; Asgeir Theodors; Thorvaldur Jonsson; Gerrit A Meijer; Jon G Jonasson Journal: Int J Cancer Date: 2017-05-19 Impact factor: 7.396
Authors: Juan Diego Morillas; Antoni Castells; Isabel Oriol; Ana Pastor; Pedro Pérez-Segura; José Manuel Echevarría; Begoña Caballero; Andrés González-Navarro; Fernando Bandrés; Enric Brullet; Antonio Iniesta; Fernando Carballo; Rosa Bouzas; Aurelio Ariza; Alfredo Ibisate; Pilar García-Alfonso; Beatriz Escudero; Silvia Camacho; Ana Fernández-Marcos; Teresa González; Enrique Quintero; Angel Lanas; Mercè Marzo; Juanjo Mascort; Monserrat Andréu; Laura Cerezo; Enrique Vázquez-Sequeiros; Josep María Borrás; Dolores Salas; Nieves Ascunce; Isabel Portillo; Mayte Herráiz; María Luisa Valle; Amalia Sotoca; Santiago Nieto; Carlos Hué; Luis Paz-Ares Journal: Gastroenterol Hepatol Date: 2012-02-23 Impact factor: 2.102
Authors: Luis Bujanda; Cristina Sarasqueta; Elisabeth Hijona; Lander Hijona; Angel Cosme; Ines Gil; Jose Luis Elorza; Jose I Asensio; Santiago Larburu; José M Enríquez-Navascués; Rodrigo Jover; Francesc Balaguer; Xavier Llor; Xavier Bessa; Montserrat Andreu; Artemio Paya; Antoni Castells Journal: World J Gastroenterol Date: 2010-02-21 Impact factor: 5.742
Authors: Robert B Hines; Milan Bimali; Asal M Johnson; A Rana Bayakly; Tracie C Collins Journal: Cancer Epidemiol Date: 2016-08-08 Impact factor: 2.984
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Arica White; Djenaba Joseph; Sun Hee Rim; Christopher J Johnson; Michel P Coleman; Claudia Allemani Journal: Cancer Date: 2017-12-15 Impact factor: 6.860